IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.590
+0.030 (1.92%)
Apr 28, 2026, 2:08 PM EDT - Market open
IN8bio Market Cap
IN8bio has a market cap or net worth of $15.66 million as of April 28, 2026. Its market cap has increased by 30.99% in one year.
Market Cap
15.66M
Enterprise Value
-8.65M
1-Year Change
30.99%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $15.66M, a decrease of -91.65%. That is a compound annual growth rate of -40.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 15.36M | -32.75% |
| Dec 31, 2025 | 22.84M | 22.52% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 17.75M |
| Cadrenal Therapeutics | 17.64M |
| Pasithea Therapeutics | 17.33M |
| Genenta Science | 16.89M |
| Theriva Biologics | 16.05M |
| Psyence Biomedical | 15.62M |
| SeaStar Medical Holding | 15.22M |
| Vyome Holdings | 14.84M |